The HemoScreen CBC Analyzer is ideal for use at oncology and hemato-oncology clinics providing a 5-part differential, platelets count, and Hb within 5 minutes in an extremely simple apparatus.
FDA-cleared for point-of-care use, HemoScreen can significantly enhance healthcare quality while simplifying oncology treatment and diagnostic workflow.
The HemoScreen analyzer enables oncologists to determine patients’ readiness for chemotherapy without delay reducing turn-around-time and entailed costs. It also facilitates real-time blood components transfusion management.
Due to the innovative machine vision technology, HemoScreen is able to detect abnormal cells including Immature Granulocytes, Blasts, and Nucleated RBCs, all early indicators of infection or inflammation. This provides a valuable tool for physicians to conclude a diagnosis or order further testing.
The HemoScreen is a miniature, portable hematology analyzer which uses disposable cartridges. Each cartridge includes all necessary reagents, after accepting the blood sample, both
reagents and samples remain safely sealed within the cartridge. The procedure is fully automatic, requiring minimal training, no maintenance, and no calibration.